Transformation and Succession: Leadership for Change

When a management leaves, more is often lost than formal responsibility: grown relationships, informal decision-making and knowledge of risks. At the same time, the company rarely faces the same tasks as at the time of the last appointment. Succession is therefore always a moment of strategic clarification.

In the healthcare market, this task is intensifying. Supply quality, product availability, approval and trust cannot be suspended during a change of leadership. Whoever combines transformation with succession must lead two time horizons at the same time: the security of today's operation and the ability to act tomorrow.

A succession is often only treated as a project when the key person announces their farewell. The requirements for the role may have long since shifted: A biotech goes from development to commercialization, a medical technology company internationalizes, a clinic group reorganizes locations and services. Anyone who reproduces only the old profile in this situation occupies the past.

Hospital reform shows how structural change and ongoing responsibility coincide. The transformation fund described by the Federal Ministry of Health is to provide up to 50 billion euros for changed care structures over ten years. [1] For providers and management, this does not automatically mean the same goal: the region, the range of services, the ability to invest and the number of employees differ considerably. A new leadership must understand the specific situation instead of implementing a general reform narrative.

Beyond the clinics, the leadership mandate is also changing. Digital processes, new regulatory requirements or a change in the ownership structure deeply affect decision-making rights and cooperation. Succession and transformation are therefore not separate personnel and strategy projects. They must be planned together.

Changing at the top creates uncertainty. Employees wonder what remains; Owners expect progress; Customers, patients or partners rely on continuity. The task is neither pure preservation nor radical restart. Good succession explicitly states what is non-negotiable – and what may be changed.

Continuity needs a conscious operating system

In regulated organizations, quality, compliance and care must not depend on a single person. Critical decisions, escalation pathways, regulatory obligations and relationships with key stakeholders must be documented and distributed across multiple shoulders before the change. This is not only risk management, but also the prerequisite for an effective start.

Change needs a real job

A successor should simultaneously guarantee stability and do everything differently? Such contradictory expectations lead to friction. Better is a prioritized mandate: What two or three changes are needed in the first 24 months? Who decides on this? What budget, governance and team are available? Without these answers, even a strong leader can hardly be effective.

The OECD describes a healthcare market for Germany with a high level of resources, but also persistent challenges in terms of efficiency and care. [2] This underscores: More resources alone do not solve organizational conflicts of goals. Leadership must set priorities and implement change through operations.

Internal candidates know products, people and informal structures. They can ensure trust and continuity. External personalities may bring experience from a transformation already accomplished and question assumptions that have become self-evident internally. Neither option is superior per se.

The decision should be measured by the concrete task of the future. An internal candidate must not only be popular, but also be able to represent the necessary changes to previous peers. An external candidate must not only have a successful reference from another company, but also be able to translate its conditions into the new context.

1. What results must the new leadership achieve after twelve and 24 months?
2. Which skills are internally available, which ones need to be added?
3. Which links to the previous system are valuable – and which hinder change?
4. How do decision-making rights and resources differ between the previous and new roles?
5. What are the risks if the decision is postponed?

A fair comparison requires the same criteria for both paths. Internal development and external market exploration can take place in parallel, provided that confidentiality and communication are properly regulated.

The contract signature ends the search, but not the succession. Especially in pharmaceuticals, medical technology and care, decisions depend on long development, approval or investment cycles. Those who only gain access to the actual conflicts on the first working day lose time and trust.

• Before the start: make responsibilities, open decisions and critical relationships transparent.
• In the transition phase: Define predecessor and successor roles with clear boundaries; No double management through the back door.
• In the first 90 days: Structuring conversations with team, owners and key interfaces before re-prioritizing programs.
• After six and twelve months: Evaluate impact based on agreed results and the health of the management system.

A good handover passes on knowledge without binding the new person to the old decision-making behavior. This also includes unpleasant topics: failed initiatives, informal resistance, regulatory burdens and conflicts of goals that are not visible in the organization chart.

Hannes Sommer begins a successor or transformation mandate with a profile workshop. Owners, advisory boards and relevant managers clarify not only technical criteria, but also the task of the next phase: stabilize, integrate, internationalize, professionalize or further develop a business model? The answer determines which experience is truly transferable.

This is followed by systematic market mapping based on personal market knowledge and supplementary research. Technology can expand the search space; It does not replace personal evaluation. The conversation is about concrete decisions under uncertainty, resistance and the ability to take an organization without compromising critical standards.

Hannes leads a maximum of three mandates in parallel and takes over qualification and calibration personally. In this way, new insights from the market can flow back into the role profile, instead of an early assumption remaining unchecked until the shortlist. The accompaniment does not end with a list of names: the handover and the arrival of the new leadership are also part of the view of a sustainable occupation.

Before addressing a market, stakeholders should specify their expectations. These questions create a common basis for decision-making:

1. What must remain stable during the changeover?
2. Which strategic task distinguishes the next phase from the previous one?
3. What decisions can the new leadership make alone – and where does the board’s responsibility begin?
4. Which internal persons are eligible and according to which criteria are they evaluated?
5. What knowledge of the departing person must be secured before the change?
6. How do we realize after a year that not only the position, but the management task was filled correctly?

If these points remain unclear, the search becomes the proxy for an unexplained strategy. A precise role, on the other hand, creates orientation for candidates and all those who support the decision.

Leadership succession in the healthcare market is a strategic transition under ongoing operation. It will be successful if companies define the future task, actively safeguard continuity and measure internal and external personalities against the same real challenge. Executive Search then not only delivers an appointment, but a better decision for the next phase of the company.